Abstract
The Argus II surgeon must ensure that the patient selected for device implantation meets all of the eligibility criteria contained in the product label, there are no contraindications to device placement, the patient’s level of residual vision contributes to a favorable risk/benefit profile, and the patient’s motivations, expectations, cognitive and communication skills, and physical abilities are likely to contribute to receiving benefit from the device. Screening typically involves a standardized survey, patient interview, and complete eye exam with biometry to determine axial length, B-scan ultrasonography to rule out a staphyloma, and macular optical coherence tomography to evaluate inner retinal anatomy.